Multiple co-occurring genetic variants in an elderly patient with Liddle's-like syndrome: a case report and literature review

Scritto il 12/11/2026
da Yunlong Liang

J Med Case Rep. 2026 Aug 25;20(1):733. doi: 10.1186/s13256-026-06473-2.

ABSTRACT

BACKGROUND: Liddle syndrome (LS) is a rare autosomal dominant condition classically defined by early-onset hypertension, hypokalemia, metabolic alkalosis, and a suppressed renin-aldosterone profile, primarily driven by gain-of-function mutations in the SCNN1A, SCNN1B, or SCNN1G genes encoding the epithelial sodium channel (ENaC). Nevertheless, genetically investigated cases exhibiting Liddle's-like phenotypes in the elderly population remain exceptionally rare.

METHODS: We report a 61-year-old male admitted with recurrent limb weakness and resistant hypertension. A comprehensive clinical workup, including biochemical profiles, RAAS evaluation, and 24-h ABPM, was conducted to exclude common secondary causes. Following informed consent, whole-exome sequencing (WES) was performed, with candidate variants validated by Sanger sequencing and assessed per ACMG/AMP guidelines. To guide therapeutic management, a narrative literature review of similar cases was also performed searching PubMed, Web of Science, and CNKI using keywords like "Liddle syndrome," "elderly," "hypertension," and "hypokalemia.".

RESULTS: Admission tests showed hypokalemia (2.94 mmol/L), compensated metabolic alkalosis, and suppressed renin-aldosterone levels. 24-h ABPM indicated severe blood pressure fluctuations up to 185/120 mmHg. Genetic testing revealed three heterozygous variants of uncertain significance (VUS)-CYP3A5 (c.1253 + 83C > T), SCNN1G (c.1727A > G, p.Lys576Arg), and WNK1 (c.5636A > T, p.Asp1879Val)-without any known pathogenic variants. A diagnostic trial with triamterene (50 mg twice daily) restored normal potassium levels (> 3.5 mmol/L). After a 30-day combination therapy of controlled-release nifedipine and irbesartan, blood pressure stabilized between 110 and 133 and 69-85 mmHg.

CONCLUSION: We report an elderly patient with chronic hypokalemia and resistant hypertension. After ruling out common secondary causes (for example, primary aldosteronism, Cushing's syndrome, pheochromocytoma), Liddle's-like syndrome was clinically diagnosed based on the low-renin/low-aldosterone biochemical phenotype, compensated metabolic alkalosis, literature review, and a selective response to triamterene. This case suggests that Liddle's-like syndrome must be considered in the differential diagnosis of hypokalemic hypertension in older adults to ensure early and targeted therapy.

PMID:43021310 | PMC:PMC13760772 | DOI:10.1186/s13256-026-06473-2